1-3 of 3
Audie Rice, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Elotuzumab on Circulating Lymphocytes, Chemokines, and Cytokines In Multiple Myeloma Patients

Lauri Neyer, PhD, Han Ding, Doreen Chen, James P Sheridan, PhD, Audie Rice, PhD, Balaji Balasa, PhD, Steve Keller, PhD, Yuni Fang, PhD, Angie Albano, Ninian Tran, Vivian Zhao, Daniel EH Afar, PhD
Journal: Blood
Blood (2010) 116 (21): 4070.
https://doi.org/10.1182/blood.V116.21.4070.4070
Published: 2010
Journal Articles

CS-1 Is Expressed in Nasal Type NK/T Cell Lymphomas and Angioimmunoblastic T-Cell Lymphomas: Implications for Targeted Therapy with Elotuzumab (HuLuc63).

Eric D Hsi, MD, Roxanne Steinle, Balaji Balasa, Audie Rice, PhD, Young-Hyeh Ko, MD, Daniel E.H. Afar, PhD
Journal: Blood
Blood (2008) 112 (11): 1779.
https://doi.org/10.1182/blood.V112.11.1779.1779
Published: 2008
Journal Articles

Eradication of Tumors in Pre-Clinical Models of Multiple Myeloma by Anti-CS1 Monoclonal Antibody HuLuc63: Mechanism of Action Studies.

Audie Rice, PhD, Myles Dillon, B.S., Anne van Abbema, M.S., Lynne Jesaitis, Ph.D, Melanie Wong, M.Sc., Stacey Lawson, B.S., Gao Liu, M.S., Yin Zhang, M.S., David Powers, PhD, Susan Rhodes, B.Sc., Ingrid Caras, PhD, Debbie Law, PhD, Daniel Afar, PhD
Journal: Blood
Blood (2006) 108 (11): 3503.
https://doi.org/10.1182/blood.V108.11.3503.3503
Published: 2006